Literature DB >> 33881475

Radiation-induced bystander effects impair transplanted human hematopoietic stem cells via oxidative DNA damage.

Linping Hu1, Xiuxiu Yin1,2, Yawen Zhang1, Aiming Pang1, Xiaowei Xie1, Shangda Yang1, Caiying Zhu1, Yapu Li1, Biao Zhang1, Yaojin Huang1, Yunhong Tian2, Mei Wang1, Wenbin Cao1, Shulian Chen1, Yawei Zheng1, Shihui Ma1, Fang Dong1, Sha Hao1, Sizhou Feng1, Yongxin Ru1, Hui Cheng1, Erlie Jiang1, Tao Cheng1.   

Abstract

Total body irradiation (TBI) is commonly used in host conditioning regimens for human hematopoietic stem cell (HSC) transplantation to treat various hematological disorders. Exposure to TBI not only induces acute myelosuppression and immunosuppression, but also injures the various components of the HSC niche in recipients. Our previous study demonstrated that radiation-induced bystander effects (RIBE) of irradiated recipients decreased the long-term repopulating ability of transplanted mouse HSCs. However, RIBE on transplanted human HSCs have not been studied. Here, we report that RIBE impaired the long-term hematopoietic reconstitution of human HSCs as well as the colony-forming ability of human hematopoietic progenitor cells (HPCs). Our further analyses revealed that the RIBE-affected human hematopoietic cells showed enhanced DNA damage responses, cell-cycle arrest, and p53-dependent apoptosis, mainly because of oxidative stress. Moreover, multiple antioxidants could mitigate these bystander effects, though at different efficacies in vitro and in vivo. Taken together, these findings suggest that RIBE impair human HSCs and HPCs by oxidative DNA damage. This study provides definitive evidence for RIBE on transplanted human HSCs and further justifies the necessity of conducting clinical trials to evaluate different antioxidants to improve the efficacy of HSC transplantation for the patients with hematological or nonhematological disorders.
© 2021 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2021        PMID: 33881475      PMCID: PMC8233686          DOI: 10.1182/blood.2020007362

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

Review 1.  Antioxidant functions of sulforaphane: a potent inducer of Phase II detoxication enzymes.

Authors:  J W Fahey; P Talalay
Journal:  Food Chem Toxicol       Date:  1999 Sep-Oct       Impact factor: 6.023

Review 2.  Radiation-induced bystander signalling in cancer therapy.

Authors:  Kevin M Prise; Joe M O'Sullivan
Journal:  Nat Rev Cancer       Date:  2009-04-20       Impact factor: 60.716

3.  Foxo3a is essential for maintenance of the hematopoietic stem cell pool.

Authors:  Kana Miyamoto; Kiyomi Y Araki; Kazuhito Naka; Fumio Arai; Keiyo Takubo; Satoshi Yamazaki; Sahoko Matsuoka; Takeshi Miyamoto; Keisuke Ito; Masako Ohmura; Chen Chen; Kentaro Hosokawa; Hiromitsu Nakauchi; Keiko Nakayama; Keiichi I Nakayama; Mine Harada; Noboru Motoyama; Toshio Suda; Atsushi Hirao
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

4.  Single-Dose Daily Fractionation Is Not Inferior to Twice-a-Day Fractionated Total-Body Irradiation Before Allogeneic Stem Cell Transplantation for Acute Leukemia: A Useful Practice Simplification Resulting From the SARASIN Study.

Authors:  Yazid Belkacemi; Myriam Labopin; Sebastian Giebel; Gokoulakrichenane Loganadane; Leszek Miszczyk; Mauricette Michallet; Gérard Socié; Nicolaas P M Schaap; Jan J Cornelissen; Ibrahim Yakoub-Agha; Emmanuelle Polge; Mohamad Mohty; Norbert Claude Gorin; Arnon Nagler
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-06-19       Impact factor: 7.038

5.  Regulation of reactive oxygen species by Atm is essential for proper response to DNA double-strand breaks in lymphocytes.

Authors:  Keisuke Ito; Keiyo Takubo; Fumio Arai; Hitoshi Satoh; Sahoko Matsuoka; Masako Ohmura; Kazuhito Naka; Masaki Azuma; Kana Miyamoto; Kentaro Hosokawa; Yasuo Ikeda; Tak W Mak; Toshio Suda; Atsushi Hirao
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

Review 6.  Treatment of severe autoimmune disease by stem-cell transplantation.

Authors:  Megan Sykes; Boris Nikolic
Journal:  Nature       Date:  2005-06-02       Impact factor: 49.962

7.  Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage.

Authors:  Hiroko P Indo; Mercy Davidson; Hsiu-Chuan Yen; Shigeaki Suenaga; Kazuo Tomita; Takeshi Nishii; Masahiro Higuchi; Yasutoshi Koga; Toshihiko Ozawa; Hideyuki J Majima
Journal:  Mitochondrion       Date:  2006-12-13       Impact factor: 4.160

8.  Antioxidant N-acetyl-L-cysteine increases engraftment of human hematopoietic stem cells in immune-deficient mice.

Authors:  Linping Hu; Hui Cheng; Yingdai Gao; Ming Shi; Yanfeng Liu; Zheng Hu; Jing Xu; Lugui Qiu; Weiping Yuan; Anskar Yu-Hung Leung; Yong-Guang Yang; Tao Cheng
Journal:  Blood       Date:  2014-10-06       Impact factor: 22.113

Review 9.  Hematologic consequences of exposure to ionizing radiation.

Authors:  Nicholas Dainiak
Journal:  Exp Hematol       Date:  2002-06       Impact factor: 3.084

10.  Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation.

Authors:  J A Snowden; R Saccardi; M Allez; S Ardizzone; R Arnold; R Cervera; C Denton; C Hawkey; M Labopin; G Mancardi; R Martin; J J Moore; J Passweg; C Peters; M Rabusin; M Rovira; J M van Laar; D Farge
Journal:  Bone Marrow Transplant       Date:  2011-10-17       Impact factor: 5.483

View more
  6 in total

1.  Associated guilt: radiation/bystanders.

Authors:  Hal E Broxmeyer
Journal:  Blood       Date:  2021-06-17       Impact factor: 22.113

Review 2.  Protection of the hematopoietic system against radiation-induced damage: drugs, mechanisms, and developments.

Authors:  Yuanyun Wei; Yaqi Gong; Shuang Wei; Yonglin Chen; Jian Cui; Xiang Lin; Yueqiu Yu; Hongxia Yan; Hui Qin; Lan Yi
Journal:  Arch Pharm Res       Date:  2022-08-11       Impact factor: 6.010

Review 3.  Recent Advancements in Poor Graft Function Following Hematopoietic Stem Cell Transplantation.

Authors:  Yan Man; Zhixiang Lu; Xiangmei Yao; Yuemin Gong; Tonghua Yang; Yajie Wang
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

Review 4.  The Hematology of Tomorrow Is Here-Preclinical Models Are Not: Cell Therapy for Hematological Malignancies.

Authors:  Lorena Arranz
Journal:  Cancers (Basel)       Date:  2022-01-24       Impact factor: 6.639

5.  Prophylactic NAC promoted hematopoietic reconstitution by improving endothelial cells after haploidentical HSCT: a phase 3, open-label randomized trial.

Authors:  Yu Wang; Yuan Kong; Hong-Yan Zhao; Yuan-Yuan Zhang; Ya-Zhe Wang; Lan-Ping Xu; Xiao-Hui Zhang; Kai-Yan Liu; Xiao-Jun Huang
Journal:  BMC Med       Date:  2022-04-27       Impact factor: 8.775

6.  Evidence for Recombinant GRP78, CALR, PDIA3 and GPI as Mediators of Genetic Instability in Human CD34+ Cells.

Authors:  Alice Fabarius; Vanessa Samra; Oliver Drews; Handan Mörz; Miriam Bierbaum; Ali Darwich; Christel Weiss; Susanne Brendel; Helga Kleiner; Wolfgang Seifarth; Wolfgang Greffrath; Wolf-Karsten Hofmann; Clemens A Schmitt; Henning D Popp
Journal:  Cancers (Basel)       Date:  2022-06-11       Impact factor: 6.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.